Aptapharma Inc.

Also on record

Records under this name other than the patents Aptapharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 6 of 6 · Back to Aptapharma Inc.

Patent	Title	Status	Expires	Confidence
US 10,064,820	Antihistamine Compositions, Combinations, and Use Thereof Lapsed on the fee record Ended Sep 4, 2026 · Medium confidence	Lapsed on the fee record	Ended Sep 4, 2026	Medium confidence
US 11,207,317	Methylnaltrexone nasal formulations, methods of making, and use thereof Lapsed on the fee record Ended Dec 28, 2025 · From the USPTO record	Lapsed on the fee record	Ended Dec 28, 2025	From the USPTO record
US 9,265,757	Methods of administering antihistamines Lapsed on the fee record Ended Feb 23, 2024 · From the USPTO record	Lapsed on the fee record	Ended Feb 23, 2024	From the USPTO record
US 10,485,770	Functionally-coated multilayer tablets Lapsed on the fee record Ended Nov 26, 2023 · From the USPTO record	Lapsed on the fee record	Ended Nov 26, 2023	From the USPTO record
US 10,485,798	Methylnaltrexone nasal formulations, methods of making, and use thereof Lapsed on the fee record Ended Nov 26, 2023 · From the USPTO record	Lapsed on the fee record	Ended Nov 26, 2023	From the USPTO record
US 10,426,724	Antihistamine Compositions, Combinations, and Use Thereof Lapsed on the fee record Ended Oct 1, 2023 · High confidence	Lapsed on the fee record	Ended Oct 1, 2023	High confidence